Shares of Evolent Health (EVH) have gained 10% over the past four weeks to close the last trading session at $33.53, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $45.50 indicates a potential upside of 35.7%.The mean estimate comprises 12 short-term price targets with a standard deviation of $7.80. While the lowest estimate of $34 indicates a 1.4% increase from the current pri ...